Medical Patent Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Pneumonia

Studies from Canada, Pakistan and Netherlands update current pneumonia data

Study 1: Current study results from the report, "Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998-2004," have been published. According to a study from Canada, "Multidrug-resistant (MDR) Streptococcus pneumoniae (i.e. resistant to three different antimicrobial classes) is a global concern. The molecular epidemiology of MDR S. pneumoniae has not been characterised in Canadian paediatric isolates. Paediatric MDR S. pneumoniae were obtained from a national surveillance study."

...

• View Other Issues of Medical Patent Law Weekly
  
• View Other NewsRx Publications